Shi Xiaohua, Song Jiayin, Chen Fenglin, Zhang Lingyu, Chen Yuanmei, Xu Wanqi, Sheng Chen, Wu Zhiyuan, Xu Zhongxin, Cui Cancan
Department of Neurology, China-Japan Union Hospital of Jilin University Jilin University Jilin China.
Department of Radiology, China-Japan Union Hospital of Jilin University Jilin University Jilin China.
J Am Heart Assoc. 2025 Jun 3;14(11):e039185. doi: 10.1161/JAHA.124.039185. Epub 2025 May 23.
The intraindividual difference between the estimated glomerular filtration rates by cystatin C and creatinine (ie, eGFRdiff) is of clinical importance. This study aimed to investigate the cross-sectional and longitudinal associations of eGFRdiff with stroke using nationally representative data from the CHARLS (China Health and Retirement Longitudinal Study).
This study included 11 869 participants (aged ≥45 years) from the CHARLS 2015 for the cross-sectional analysis. A total of 11 553 participants free of stroke were recruited in 2015 as baseline and followed up to 2020 for the cohort analysis. The eGFRdiff was calculated by subtracting estimated glomerular filtration rate by serum creatinine from estimated glomerular filtration rate by serum cystatin C at baseline. Logistic regression models and Cox proportional hazards models were used to examine the cross-sectional and longitudinal associations.
The mean age of the participants was 60.3±9.6 years, and 5514 (46.5%) were men. According to the cross-sectional analysis, a negative eGFRdiff was associated with a greater prevalence of stroke (odds ratio per 1 SD, 0.841 [95% CI, 0.741-0.955]). During a median follow-up of 5.0 years, 838 individuals (7.3%) experienced incident stroke. A lower baseline eGFRdiff was associated with a greater risk of stroke onset (hazard ratio [HR] per 1 SD, 0.884 [95% CI, 0.817-0.955]). Compared with those in the midrange eGFRdiff group (from -15 to 15 mL/min per 1.73 m), those in the negative eGFRdiff group (<-15 mL/min per 1.73 m) exhibited a significantly increased risk of incident stroke (HR, 1.202 [95% CI, 1.026-1.407]).
A large negative eGFRdiff was independently associated with higher prevalence and incidence rates of stroke among middle-aged and older Chinese adults.
胱抑素C和肌酐估算的肾小球滤过率之间的个体内差异(即,估算肾小球滤过率差异[eGFRdiff])具有临床重要性。本研究旨在利用中国健康与养老追踪调查(CHARLS)具有全国代表性的数据,探讨eGFRdiff与中风的横断面和纵向关联。
本研究纳入了CHARLS 2015年的11869名参与者(年龄≥45岁)进行横断面分析。2015年共招募了11553名无中风的参与者作为基线,并随访至2020年进行队列分析。eGFRdiff通过在基线时用血清胱抑素C估算的肾小球滤过率减去血清肌酐估算的肾小球滤过率来计算。采用逻辑回归模型和Cox比例风险模型来检验横断面和纵向关联。
参与者的平均年龄为60.3±9.6岁,5514名(46.5%)为男性。根据横断面分析,eGFRdiff为负与中风患病率较高相关(每1个标准差的比值比,0.841[95%置信区间,0.741 - 0.955])。在中位随访5.0年期间,838人(7.3%)发生了中风。较低的基线eGFRdiff与中风发病风险较高相关(每1个标准差的风险比[HR],0.884[95%置信区间,0.817 - 0.955])。与eGFRdiff处于中等范围组(每1.73平方米为-15至15毫升/分钟)相比,eGFRdiff为负组(每1.73平方米<-15毫升/分钟)发生中风的风险显著增加(HR,1.202[95%置信区间,1.026 - 1.407])。
在中国中老年成年人中,较大的负eGFRdiff与中风的较高患病率和发病率独立相关。